Add like
Add dislike
Add to saved papers

Nonthermal control of Escherichia coli growth using extremely low frequency electromagnetic (ELF-EM) waves.

BACKGROUND: Escherichia coli (E. coli) bacteria normally live in the intestines of people and animals. Most E. coli are harmless and the treatment of the infection could be achieved by using antibiotics, however the effectiveness is still debatable and needs more investigation.

OBJECTIVE: Researching the inhibition resonance frequency of square amplitude modulating waves (QAMW) that can inhibit the growth activity of E. coli and its ability to make division.

METHODS: A range of different extremely low frequencies of square amplitude modulated waves (QAMW) from 0.1 to 1.0 Hz from two generators with a constant carrier frequency of 10 MHz, amplitude of 10 Vpp, modulating depth ± 2 Vpp and constant field strength 200 V/m were used to treat E. coli cells at 37 °C.

RESULTS: The exposure of E. coli to 0.3 Hz QAMW for 90 min was the most inhibited frequency where the bacterial growth inhibited by 42.3%. Furthermore, a significant increase in antibiotic susceptibility to protein and cell wall inhibitors was investigated. Also, results of the chromosomal DNA sequences, dielectric relaxation and TEM indicated highly significant molecular and morphological changes after the exposure.

CONCLUSIONS: We concluded that the exposure of E. coli to QAMW at the inhibiting frequency interfered with the bioelectric signals generated from the bacteria during the cell division and changed the cellular activity and DNA sequences, and these changes lead to a significant inhibition of the bacterial growth. This is a new promising technique that aids to avoid the repetitive use of antibiotics against the bacterial pathogens.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app